Interfraction variation and dosimetric changes during image-guided radiation therapy in prostate cancer patients.
Image-guided radiotherapy
Intensity-modulated radiotherapy
Prostatic neoplasms
Rectum
Urinary bladder
Journal
Radiation oncology journal
ISSN: 2234-1900
Titre abrégé: Radiat Oncol J
Pays: Korea (South)
ID NLM: 101577577
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
20
11
2018
accepted:
15
03
2019
pubmed:
29
5
2019
medline:
29
5
2019
entrez:
29
5
2019
Statut:
ppublish
Résumé
The aim of this study was to identify volume changes and dose variations of rectum and bladder during radiation therapy in prostate cancer (PC) patients. We analyzed 20 patients with PC treated with helical tomotherapy. Daily image guidance was performed. We re-contoured the entire bladder and rectum including its contents as well as the organ walls on megavoltage computed tomography once a week. Dose variations were analyzed by means of Dmedian, Dmean, Dmax, V10 to V75, as well as the organs at risk (OAR) volume. Further, we investigated the correlation between volume changes and changes in Dmean of OAR. During treatment, the rectal volume ranged from 62% to 223% of its initial volume, the bladder volume from 22% to 375%. The average Dmean ranged from 87% to 118% for the rectum and 58% to 160% for the bladder. The Pearson correlation coefficients between volume changes and corresponding changes in Dmean were -0.82 for the bladder and 0.52 for the rectum. The comparison of the dose wall histogram (DWH) and the dose volume histogram (DVH) showed that the DVH underestimates the percentage of the rectal and bladder volume exposed to the high dose region. Relevant variations in the volume of OAR and corresponding dose variations can be observed. For the bladder, an increase in the volume generally leads to lower doses; for the rectum, the correlation is weaker. Having demonstrated remarkable differences in the dose distribution of the DWH and the DVH, the use of DWHs should be considered.
Identifiants
pubmed: 31137087
pii: roj.2018.00514
doi: 10.3857/roj.2018.00514
pmc: PMC6610012
doi:
Types de publication
Journal Article
Langues
eng
Pagination
127-133Références
Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):265-78
pubmed: 11316572
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):261-8
pubmed: 12023128
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1111-6
pubmed: 12128109
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1589-601
pubmed: 15590191
Radiat Oncol. 2006 Sep 06;1:34
pubmed: 16956403
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):876-82
pubmed: 17011460
N Engl J Med. 2008 Mar 20;358(12):1250-61
pubmed: 18354103
Strahlenther Onkol. 2009 Sep;185(9):588-95
pubmed: 19756425
Radiother Oncol. 2010 May;95(2):198-202
pubmed: 20303193
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9
pubmed: 22330997
Radiother Oncol. 2012 Nov;105(2):180-3
pubmed: 23182056
Phys Med Biol. 2013 Apr 7;58(7):N115-23
pubmed: 23475338
Radiother Oncol. 2013 Dec;109(3):493-7
pubmed: 24044793
Br J Radiol. 2014 Oct;87(1042):20140343
pubmed: 25138155
Med Dosim. 2015 Autumn;40(3):222-5
pubmed: 25683282
J Med Imaging Radiat Oncol. 2015 Aug;59(4):507-13
pubmed: 25828420
Radiat Oncol. 2016 Aug 02;11:103
pubmed: 27485637
Strahlenther Onkol. 2017 Jan;193(1):38-45
pubmed: 27909738
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1321-9
pubmed: 7493857
Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):1105-11
pubmed: 9276378